Join
Live feed
·
INSIDERFilingvia Quantisnow
Syndax Pharmaceuticals Inc. logo

Chief Executive Officer Metzger Michael A was granted 217,600 shares and sold $152,835 worth of shares (7,412 units at $20.62), increasing direct ownership by 70% to 508,849 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNDX (Syndax Pharmaceuticals Inc.) and more on Quantisnow.